Active Ingredient(s): Semaglutide
FDA Approved: * June 4, 2021
Pharm Company: * NOVO
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Wegovy Overview

Semaglutide, sold under the brand name Ozempic among others, is an anti-diabetic medication used for the treatment of type 2 diabetes and chronic weight management.[11][12][13] Semaglutide acts like human glucagon-like peptide-1 (GLP-1) such that it increases insulin secretion, thereby increasing sugar metabolism. It is distributed as a metered subcutaneous injection in a prefilled pen or as an oral form. One of its advantages over other antidia...

Read more Wegovy Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Semaglutide

Recent Wegovy Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 0.25mg/0.5ml (0.25mg/0.5ml), 0.5mg/0.5ml (0.5mg/0.5ml), 1.7mg/0.75ml (1.7mg/0.75ml), 1mg/0.5ml (1mg/0.5ml), 2.4mg/0.75ml (2.4mg/0.75ml), 2mg/1.5ml (1.34mg/ml), 4mg/3ml (1.34mg/ml)
  • Tablet: 14mg, 3mg, 7mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Wegovy: (5 results)

Sorted by National Drug Code
  • 0169-4501 Wegovy 1 mg/.5ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-4505 Wegovy .5 mg/.5ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-4517 Wegovy 1.7 mg/.75ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-4524 Wegovy 2.4 mg/.75ml Subcutaneous Injection, Solution by Novo Nordisk
  • 0169-4525 Wegovy .25 mg/.5ml Subcutaneous Injection, Solution by Novo Nordisk

Other drugs which contain Semaglutide or a similar ingredient: (3 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 25 July 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA